[Immunofluorescence and post-commissurotomy or post-infarct syndromes].
D000328:Adult; D000368:Aged; D001323:Autoantibodies; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D005260:Female; D005455:Fluorescent Antibody Technique; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D008946:Mitral Valve Stenosis / Q000601:surgery*; D009203:Myocardial Infarction / Q000150:complications*; D009206:Myocardium / Q000276:immunology*; D009210:Myofibrils / Q000276:immunology; D011183:Postoperative Complications / Q000188:drug therapy / Q000276:immunology; D011185:Postpericardiotomy Syndrome / Q000276:immunology; D012459:Salicylates / Q000627:therapeutic use; D012508:Sarcolemma / Q000276:immunology
D001323:Autoantibodies; D005938:Glucocorticoids; D012459:Salicylates
Immunofluorescence et syndromes post-commisurotomie ou post-infarctus.